Biogen Idec (BIIB)
News
| May 26 | 7 Biotech Stocks to Add to Your Portfolio Investor Place |
| May 25 | High Profitability and Low Valuation for Gilead Fool |
| May 25 | $BIIB she's gonna break 135 by mondays |
| May 24 | Wondering Which Stocks to Sell? There’s a List and We Explain How to Read It http://stks.co/3ysW $NFLX $PCS $EA $BIIB $CBS $COG $DF by ycharts |
| May 23 | $BIIB ss 131.55 by gordonstoun |
| May 23 | $BIIB not joining the fun 131 by gordonstoun |
| May 20 | Top 5 Healthcare by 14 period RSI: $PFE $EW $BIIB $ABT $LLY (S&P 500) $VRTX $ARNA $AMLN $AKRX $SEM (non S&P 500) by TheEquitiesRoom |
| May 18 | Biogen Idec Inc (BIIB): Today's Featured Health Care Loser |
| May 18 | Data on Elan & Biogen's Tysabri |
| May 18 | $BIIB http://stks.co/3tiV Daily CCI diveregence and reached target today under 20sma daily support http://stks.co/3tiW by xpertstocktrader |
| May 18 | S&P 500 Annual Meeting Calendar, Week of May 21 - June 15 |
Profile
Exchange: NASDAQGS Sector: Healthcare Industry: Biotechnology
Biogen Idec, Inc. is a biotechnology company specializing in drugs for neurological disorders, autoimmune disorders and cancer. The company was formed in 2003 by the merger of Cambridge, Massachusetts-based Biogen Inc. and San Diego, California-based IDEC Pharmaceuticals . Biogen, one of the oldest biotechnology companies, was founded in 1978 in Geneva by several biologists, including Phillip Sharp of the Massachusetts Institute of Technology, Walter Gilbert of Harvard and Charles Weissmann of Zurich University .
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Biogen Idec is up 41.14% over the last year vs S&P 500 Total Return up 1.62%, Amgen up 18.79%, and Celgene Corporation up 15.06%.
- BIIB Total Returns
- ^SPXTR Total Returns
- AMGN Total Returns
- CELG Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these BIIB related companies
Pro Strategies Featuring BIIB
Did Biogen Idec make it into our Pro Portfolio Strategies?
BIIB Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other BIIB Resources
- Company Website
- Wiki Page
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BIIB | 131.56 | -0.09 | -0.07% | 31.41B |
| BIG | 37.30 | +1.55 | +4.34% | 2.469B |
| BIF | 5.73 | +0.01 | +0.17% | |
| BIDZ | 0.76 | +0.01 | +0.66% | 13.97M |
| BDN | 11.29 | -0.07 | -0.62% | 1.611B |
| BDMS | 16.95 | -0.04 | -0.23% | 31.19M |
| BDL | 7.30 | +0.11 | +1.53% | 13.58M |
| BDJ | 7.16 | +0.02 | +0.28% | |
| BDGE | 19.78 | +0.00 | +0.00% | 167.54M |
| BDE | 9.14 | +0.09 | +0.99% | 280.42M |
